Bioxytran Inc (BIXT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 80 | 45 | 154 | 295 | 374 |
| TOTAL | $80 | $45 | $154 | $295 | $374 |
| Non-Current Assets | |||||
| Intangibles | 109 | 98 | 80 | 76 | 74 |
| TOTAL | $109 | $98 | $80 | $76 | $74 |
| Total Assets | $189 | $143 | $234 | $371 | $449 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 378 | 763 | 2,076 | 1,464 | 803 |
| Other current liabilities | 55 | 6 | 53 | 39 | 37 |
| TOTAL | $2,333 | $2,769 | $4,294 | $3,668 | $2,998 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 35 | 1 | 33 | 51 | 80 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,333 | $2,769 | $4,294 | $3,668 | $2,998 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 144,642 | 132,535 | 130,596 | 123,502 | 123,014 |
| Common Shares | 144 | 132 | 124 | 123 | 123 |
| Retained earnings | -14,451 | -13,414 | -12,003 | -11,227 | -10,412 |
| Other shareholders' equity | -659 | -624 | -624 | -591 | -540 |
| TOTAL | $-2,144 | $-2,626 | $-4,061 | $-3,297 | $-2,549 |
| Total Liabilities And Equity | $189 | $143 | $234 | $371 | $449 |